Author:
Cone L A,Woodard D R,Stoltzman D S,Byrd R G
Abstract
A prospective, randomized study was undertaken to compare the efficacy and safety of ceftazidime with those of a combination of ticarcillin and tobramycin in the treatment of 40 nonneutropenic patients with pneumonia or bacteremia. Altogether, 93% of the patients receiving ceftazidime for pneumonia were cured, and 87% of those with bacteremia responded favorably. Of the subjects who were treated with ticarcillin and tobramycin ceftazidime developed significant superinfection, and one individual treated with the aminoglycoside and carboxypenicillin developed reversible azotemia. Ceftazidime appears to be as efficacious as the ticarcillin-tobramycin combination and is probably safer with regard to oto-and nephrotoxicity; however, superinfections did occur more frequently in the group treated with ceftazidime.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference32 articles.
1. Allen S. G. S. C. Glover C. C. Smith K. M. Hadley T. M. S. Reid K. Han J. M. Murdoch and P. M. Ingram. 1983. An open study of ceftazidime in the treatment of serious bacterial infection. J. Antimicrob. Chemother. 8(Suppl. B):311-312.
2. Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits;Baker R. L.;Antimicrob. Agents Chemother.,1984
3. A survey of prospective, controlled clinical trials of gentamicin, tobramycin, amikacin, and netilmicin;Cone L. A.;Clin. Ther.,1982
4. Antibiotic synergism and antimicrobial combinations in clinical infections;Eliopoulos G. M.;Rev. Infect. Dis.,1982
5. Cefotaxime versus ampicillin, methicillin and netilmicin in combination for the treatment of febrile episodes in patients with haematologic malignancy;Friis H.;Acta Med. Scand.,1983
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献